2 Key Tips To Own The ‘Childless By Choice’ Trend, By A Psychologist
Forbes· 3 日前Traditional wisdom suggests that we all have an innate desire to have kids, and not giving in to this desire comes at the ...
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
CNBC· 4 日前Pfizer's twice-daily version of its experimental weight loss pill has now joined a long ...
China implements measures to address surge in respiratory infectious diseases - Dimsum Daily
Dimsum Daily· 4 日前2nd December 2023 – (Beijing) In response to a recent increase in respiratory infectious diseases, medical authorities in ...
Without RCT, FDA May Consider Approval Of A Cross-Sex Hormone For Gender-Affirming Care
Forbes· 4 日前The Food and Drug Administration may consider approval of the cross-sex hormone estradiol for ...
Why Pfizer's latest stumble in the obesity market is a boon for Eli Lilly
CNBC· 5 日前Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and ...
Weight-Loss Drugs Are a Gold Mine, and Just as Elusive
Bloomberg· 5 日前On Friday, Pfizer Inc. announced that it’s dropping development of an experimental weight-loss ...
Stocks making the biggest moves midday: Tesla, Disney, Alibaba, Ulta Beauty and more
CNBC· 5 日前These are the stocks posting the largest moves in midday trading.
Pfizer drops twice-daily version of obesity pill over side effects
Reuters· 5 日前Pfizer (PFE.N) said on Friday it would not advance a twice-daily version of oral weight-loss ...
Why investors should stick with Eli Lilly
CNBC· 5 日前Every weekday the CNBC Investing Club with Jim Cramer holds a Morning Meeting livestream at ...
Stocks making the biggest moves premarket: Pfizer, Disney, Tesla, Alibaba and more
CNBC· 5 日前... 4.2% after the drugmaker said it would halt development of its twice-daily experimental ...
